Masayuki Matsuo

Masayuki Matsuo

Auto-generated profile, based on publicly available information

Masayuki Matsuo

Department of Radiology, Gifu University School of Medicine, Gifu, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
MMMasayuki Matsuo
Masayuki Matsuo
KMKazuhiro Miwa
Kazuhiro Miwa
OTOsamu Tanaka
Osamu Tanaka
JSJun Shinoda
Jun Shinoda
HNHironori Nishibori
Hironori Nishibori
HAHidefumi Aoyama
Hidefumi Aoyama

1 April 2000 in American Journal of Roentgenology
Verified
Journal Article
Closed access
HKHiroshi Kondo
Hiroshi Kondo
MKMasayuki Kanematsu
Masayuki Kanematsu
HHHiroaki Hoshi
Hiroaki Hoshi
TMTakamichi Murakami
Takamichi Murakami
TKTonsok Kim
Tonsok Kim
HNHironobu Nakamura
Hironobu Nakamura
OBJECTIVE. We compared radiologists' performance on combined unenhanced, gadolinium-enhanced, and ferumoxides-enhanced MR imaging with their performance on helical CT during arterial portography (CTAP) and biphasic CT during hepatic arteriography (CTHA) for the preoperative detection of malignant hepatic tumors. SUBJECTS AND METHODS. MR images and CT scans obtained in 33 patients were retrospectively analyzed. Images of the liver were reviewed on a segment-by-segment basis; a total of 261 segments with 39 hepatocellular carcinomas and 21 metastases were independently reviewed by three radiologists who were invited from outside institutions. Unenhanced and gadolinium-enhanced MR images were reviewed first, then ferumoxides-enhanced MR images were added for combined review. CTAP images and biphasic CTHA images were reviewed together. RESULTS. Sensitivity for the detection of hepatic tumors was analogous for combined unenhanced, gadolinium-enhanced, and ferumoxides-enhanced MR images (86%) and for combined CTAP images and biphasic CTHA images (87%). Specificity was higher with MR images (95%, p < 0.01) than with CT images (91%). Radiologists' performances were improved (Az = 0.962, p = 0.0502) by combining ferumoxides-enhanced MR images with unenhanced and gadolinium-enhanced MR images (Az) = 0.950), and were analogous for combined unenhanced, gadolinium-enhanced, and ferumoxides-enhanced MR images and for combined CTAP images and biphasic CTHA images (Az = 0.959). CONCLUSION. Radiologists' performances on combined unenhanced, gadolinium-enhanced, and ferumoxides-enhanced MR imaging compared with their performances on combined helical CTAP and biphasic CTHA are analogous for the preoperative detection of malignant hepatic tumors. Such a dedicated combination of MR imaging may obviate the need for more invasive angiographically assisted helical CT for the preoperative detection of malignant hepatic tumors.

1 September 2001 in American Journal of Roentgenology
Verified
Journal Article
Closed access
MMMasayuki Matsuo
Masayuki Matsuo
MKMasayuki Kanematsu
Masayuki Kanematsu
KIKyo Itoh
Kyo Itoh
KIKatsuyoshi Ito
Katsuyoshi Ito
YMYoji Maetani
Yoji Maetani
JSJunji Shiraishi
Junji Shiraishi
OBJECTIVE. The purpose of our study was to compare how well gadolinium-enhanced and ferumoxide-enhanced MR imaging reveal malignant hepatic tumors. SUBJECTS AND METHODS. Both gadolinium-enhanced and ferumoxide-enhanced MR imaging were separately performed in 53 patients with a total of 87 malignant hepatic tumors (57 hepatocellular carcinomas, 28 metastases, two cholangiocarcinomas). Thirty-one of the 53 patients had hepatic cirrhosis. Images were reviewed by three independent off-site observers. Observer performance was evaluated by means of sensitivity, specificity, and receiver operating characteristic curve analyses. RESULTS. Gadolinium-enhanced MR imaging outperformed ferumoxide-enhanced MR imaging in sensitivity (81% versus 62%, p < 0.01) for malignant-tumor detection. Specificity was comparable (94%) between the two types of MR imaging. Area under receiver operating characteristic curve (Az) value was significantly higher with gadolinium-enhanced MR imaging than with ferumoxide-enhanced MR imaging in patients overall (Az = 0.896 versus 0.805, p < 0.001), in patients with cirrhosis (Az = 0.907 versus 0.807, p < 0.001), and in patients without cirrhosis (Az = 0.899 versus 0.834, p < 0.01). The superiority was enhanced in the subset of patients with cirrhosis. CONCLUSION. Gadolinium-enhanced MR imaging outperforms ferumoxide-enhanced MR imaging in revealing malignant hepatic tumors. Gadolinium-enhanced MR imaging is recommended, particularly for patients with cirrhosis.

16 July 2004 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
SGSatoshi Goshima
Satoshi Goshima
MKMasayuki Kanematsu
Masayuki Kanematsu
MMMasayuki Matsuo
Masayuki Matsuo
HKHiroshi Kondo
Hiroshi Kondo
HKHiroki Kato
Hiroki Kato
NMNoriyuki Moriyama
Noriyuki Moriyama
Purpose To perform comparison of gadolinium‐enhanced and ferumoxides‐enhanced magnetic resonance imaging (MRI) in the detection of nodule‐in‐nodule appearance of hepatocellular carcinomas (HCCs). Materials and Methods During a recent 45‐month period, we had eight patients (five men and three women; age range, 63–84 years; mean, 71 years) with HCCs with nodule‐in‐nodule appearance who underwent gadolinium‐enhanced MRI, ferumoxides‐enhanced MRI, and computed tomography during arterial portography (CTAP) and computed tomography during hepatic arteriography (CTHA), combined and separately, within an interval of two weeks. Two blinded radiologists in consensus retrospectively evaluated three sets of sequences: unenhanced T1‐ and T2‐weighted MR, gadolinium‐enhanced MR, and ferumoxides‐enhanced MR images in random order of patients and imaging sequences. The depiction degree of nodule‐in‐nodule appearance of HCC was evaluated in a semiquantitative fashion. The sensitivities of unenhanced T1‐ and T2‐weighted, gadolinium‐enhanced, and ferumoxides‐enhanced MR images were compared with McNemar's test. Results The eight HCCs with nodule‐in‐nodule appearance ranged in size from 16–26 mm (mean, 20.0 ± 4.0 mm), and there existed nine internal HCC foci ranging in size from 5–14 mm (mean, 7.9 ± 3.5 mm). On gadolinium‐enhanced MR images, the nodule‐in‐nodule appearance of HCC was typically seen as hypervascular foci in an iso‐ or hypovascular area: the depiction degree of nodule‐in‐nodule appearance was distinct in two lesions, equivocal in three, and absent in three. On ferumoxides‐enhanced MR images, it was typically seen as hyperintense foci in a hypointense area: the depiction degree was distinct in four, moderate in one, and absent in three. The sensitivities for detection of nodule‐in‐nodule appearance were 25%, 25%, and 63% on T1‐ and T2‐weighted, gadolinium‐enhanced, and ferumoxides‐enhanced MR images, respectively, but there was no significant difference in sensitivity. Conclusion Nodule‐in‐nodule appearance of HCCs can be seen on ferumoxides‐enhanced MR images, in some cases more clearly than on gadolinium‐enhanced MR images, particularly when the background nodule shows hyperintensity on precontrast T1‐weighted images. Ferumoxides‐enhanced MRI may be considered when development of malignant foci is suspected during routine examinations. J. Magn. Reson. Imaging 2004;20:250–255.

13 June 2003 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
MKMasayuki Kanematsu
Masayuki Kanematsu
MMMasayuki Matsuo
Masayuki Matsuo
YYYasuhiro Yamada
Yasuhiro Yamada
RSRichard C. Semelka
Richard C. Semelka
HKHiroshi Kondo
Hiroshi Kondo
NMNoriyuki Moriyama
Noriyuki Moriyama
Purpose To correlate the perilesional hyperintense rim of malignant hepatic tumors seen on ferumoxide‐enhanced T1‐weighted gradient‐echo (GE) MR images with histopathologic findings. Materials and Methods In 13 tumors in 12 patients, T1‐weighted GE images (TE of 1.4 msec, flip angle of 90 degrees) obtained after IV administration of ferumoxide were evaluated. MR imaging was initiated within one hour of the completion of ferumoxide administration. Surgical resection for tumors was performed within an interval of two weeks of the MR imaging. Resected specimens were histopathologically examined for peritumoral sinusoidal congestion, desmoplastic reaction, compressed hepatic parenchyma, lymphocytic infiltration, and vascular proliferation. Results In twelve tumors (92%), prominently (N = 2), moderately (N = 5), and mildly to minimally (N = 5), a perilesional hyperintense rim was observed. Among histopathologic findings, the degree of peritumoral sinusoidal congestion correlated (R = .75, P < .04) with the degree of perilesional hyperintense rim. The thickness of the perilesional hyperintense rim showed a moderate positive correlation (R = .65, P < .02) with the thickness of peritumoral area with sinusoidal congestion. Conclusion Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide‐enhanced T1‐weighted GE images may correlate with sinusoidal congestion surrounding malignant hepatic tumors. J. Magn. Reson. Imaging 2003;18:40–48.

21 June 2004 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
SGSatoshi Goshima
Satoshi Goshima
MKMasayuki Kanematsu
Masayuki Kanematsu
MMMasayuki Matsuo
Masayuki Matsuo
HKHiroshi Kondo
Hiroshi Kondo
NKNobuo Kako
Nobuo Kako
NMNoriyuki Moriyama
Noriyuki Moriyama
Purpose To determine whether chemical‐shift‐selective (CSS) fat suppression is necessary for ferumoxide‐enhanced T2‐weighted fast spin‐echo (FSE) imaging in the detection of malignant hepatic tumors. Materials and Methods Ferumoxide‐enhanced magnetic resonance (MR) images obtained in 38 patients with surgically confirmed 61 malignant hepatic tumors (36 hepatocellular carcinomas (HCCs), 25 metastases) were retrospectively reviewed by three independent readers. Three sequences of MR images with CSS fat‐suppressed T2‐weighted FSE, non‐fat‐suppressed T2‐weighted FSE, and T2*‐weighted gradient‐recalled‐echo (GRE) sequences were randomly reviewed on a segment‐by‐segment basis in a blind fashion. Observer performance was tested using the McNemar's test and receiver‐operating‐characteristic (ROC) analysis for the clustered data. Lesion‐to‐liver contrast‐to‐noise ratio (C/N) was also assessed. Results The mean C/N with the CSS fat‐suppressed FSE sequence was highest in HCCs, metastases, and tumors overall. Sensitivity was highest with the CSS fat‐suppressed FSE sequence in HCC, was highest with the non‐fat‐suppressed FSE sequence in metastases, and was comparable in tumors overall. Specificity was comparable between the sequences. The area under ROC curve (Az) value was greatest with the CSS fat‐suppressed FSE sequence in HCCs, was greatest with the non‐fat‐ suppressed FSE sequence in metastases, and was comparable in tumors overall. The sensitivities and Az values were lower with the GRE sequence than the FSE sequence. Conclusion The CSS fat‐suppressed FSE sequence was superior to the GRE sequence in the detection of HCCs, but the non‐fat‐suppressed FSE sequence was comparable to the GRE sequence. The non‐fat‐suppressed FSE sequence was superior to the CSS fat‐suppressed FSE and GRE sequences in the detection of metastases. Optimal FSE imaging with CSS fat suppression or without aiming for the detection of HCCs or metastases, respectively, outperforms GRE imaging in ferumoxide‐enhanced MRI. J. Magn. Reson. Imaging 2004;20:75–82.